GENEVA, April 6 -- NOEMA PHARMA AG (Barfusserplatz 34051 Basel) filed a patent application (PCT/EP2025/077416) for "USE OF PHOSPHODIESTERASE 10 INHIBITOR GEMLAPODECT FOR WEIGHT LOSS" on Sep 25, 2025. With publication no. WO/2026/068583, the details related to the patent application was published on Apr 02, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): LOMBARDO, Ilise (c/o Noema Pharma AGBarfusserplatz 34051 Basel), LASSER, Robert (c/o Noema Pharma AGBarfusserplatz 34051 Basel), JONAS, Jeffrey (c/o Noema Pharma AGBarfusserplatz 34051 Basel)
Abstract: Provided herein are methods of reducing...